Verified peer comparison
Cytosorbents vs Elicio Therapeutics Financial Comparison
Direct answer
Cytosorbents and Elicio Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Cytosorbents email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Cytosorbents Revenue
- 37,063,000 USD
- Elicio Therapeutics Revenue
- 0 USD
- Cytosorbents Operating income
- -14,239,000 USD
- Elicio Therapeutics Operating income
- -37,714,000 USD